Functionalized protein nanoemulsions by incorporation of chemically modified BSA

Ana Loureiro, Ana S. Abreu, Marisa Passos Sárria, Mafalda C O Figueiredo, Lígia M. Saraiva, Gonc¸alo J L Bernardes, Andreia C. Gomes, Artur Cavaco-Paulo

Research output: Contribution to journalArticlepeer-review

15 Citations (Scopus)

Abstract

The incorporation of bioactive compounds in stealth nanoparticles or nanoemulsions enhances their half-life in systemic circulation and can overcome the problems associated with the free drug. Bovine serum albumin (BSA)-drug conjugates were produced with either methotrexate (MTX), a potent anticancer agent, or vancomycin (VCM), a potent antibiotic. Those conjugates were used to produce functionalized BSA nanoemulsions in a formulation composed of an aqueous phase and an organic phase. BSA-folic acid (FA) conjugates were also produced allowing specific folate receptor (FR) mediated targeting of cancer cells (KB cell line). All conjugates had similar effects either in solution or in the form of nanoemulsions: BSA-MTX as an anti-proliferative over the Caco-2 cell line and BSA-VCM with a lower minimum inhibitory concentration (MIC) compared to VCM solution on the Staphylococcus aureus strain Newman. The production of nanoemulsions using BSA-drug conjugates for obtaining vectors loaded with stabilized drugs offers a good, flexible template for a wide range of medical applications.

Original languageEnglish
Pages (from-to)4976-4983
Number of pages8
JournalRCS Advances
Volume5
Issue number7
DOIs
Publication statusPublished - 2015

Fingerprint

Dive into the research topics of 'Functionalized protein nanoemulsions by incorporation of chemically modified BSA'. Together they form a unique fingerprint.

Cite this